SEC Form 13F Information Table Summary
Business Context and Reporting Period
This filing is a Form 13F Information Table submitted by Kinsale Capital Group, Inc. for the reporting period ending December 31, 2022. The document discloses the company's holdings of equity securities as of the end of the quarter. It is a regulatory disclosure of investment positions and does not contain operational financial statements for Kinsale Capital Group itself.
Key Financial Metrics and Holdings
The filing details a portfolio of 25 distinct equity positions, including individual stocks and mutual funds. Voting authority for all listed securities is reported as Sole discretion.
| Security Name | Shares Held | Value (USD) |
|---|---|---|
| Vanguard Index Fds Total Stk Mkt | 326,312 | $62,387,568 |
| Vanguard Whitehall Fds High Div Yld | 386,418 | $41,814,275 |
| Chevron Corp New Com | 4,640 | $832,834 |
| Exxon Mobil Corp Com | 7,480 | $825,044 |
| Johnson & Johnson Com | 4,525 | $799,341 |
| Arch Cap Group Ltd Ord | 6,400 | $401,792 |
| Progressive Corp Com | 3,150 | $408,587 |
| International Flavors&Fragra Com | 3,900 | $408,876 |
| Philip Morris Intl Inc Com | 4,000 | $404,840 |
| L3Harris Technologies Inc Com | 1,945 | $404,968 |
| Visa Inc Com Cl A | 1,946 | $404,301 |
| Apple Inc Com | 3,020 | $392,389 |
| McKesson Corp Com | 1,045 | $392,000 |
| Walgreens Boots Alliance Inc Com | 10,500 | $392,280 |
| Walmart Inc Com | 2,780 | $394,176 |
| Home Depot Inc Com | 1,260 | $397,984 |
| Lockheed Martin Corp Com | 822 | $399,895 |
| Amgen Inc Com | 1,510 | $396,586 |
| Dollar Gen Corp New Com | 1,650 | $406,313 |
| Humana Inc Com | 800 | $409,752 |
| Williams Cos Inc Com | 6,145 | $202,171 |
| Wabtec Com | 2,020 | $201,616 |
| Paccar Inc Com | 2,000 | $197,940 |
| Grainger W W Inc Com | 355 | $197,469 |
| Autozone Inc Com | 170 | $419,251 |
Note: Revenue, profit, cash flow, margins, debt, and liquidity metrics for Kinsale Capital Group are not provided in this filing type.
Material Changes and Outlook
This filing is a snapshot of holdings at a specific date and does not provide comparative data against prior periods, management commentary, guidance, or risk factors. Consequently, material changes in portfolio composition, outlook, or contingencies cannot be determined from this document alone.
Investor Verification Checklist
- Verify the total aggregate value of the reported portfolio against the company's latest 10-K or 10-Q filings to assess asset allocation.
- Confirm the classification of "Sole" voting authority for all listed securities.
- Review the specific CUSIP numbers to ensure accurate identification of the securities held.
- Check subsequent 13F filings to track changes in the Vanguard fund positions, which represent the largest portion of the reported value.